Literature DB >> 17377098

An economic analysis of costs associated with development of a cell salvage program.

Janet Robinson Waters1, Heidi Hylton Meier, Jonathan H Waters.   

Abstract

BACKGROUND: The increasing cost of blood products and associated risks of transfusion have lead to a heightened interest in techniques which reduce or replace allogeneic blood transfusion. The use of cell salvage is being explored in a number of institutions. We present financial information which may be useful to institutions that are considering the addition of a cell salvage service.
METHODS: A review of the cell salvage data from 2328 patients was used to estimate the average cost of a packed red blood cell unit equivalent processed by cell salvage equipment. In addition, an analysis was performed to assess the break-even point of establishing a cell salvage service.
RESULTS: Initial capital outlay to establish a cell salvage service at this institution was $103,551. The annual fixed operating cost was $250,943. The average cost of transfusion of an allogeneic packed red blood cell unit was $200. For an equivalent cell salvage unit, the cost was $89.46. The payback period was 1.9 mo.
CONCLUSION: This analysis suggests that cell salvage can be significantly less expensive than allogeneic blood. The cost of cell salvage in other institutions will vary depending upon case volume, expected levels of blood loss per case, and initial investment costs. A step-by-step formula is provided to assist in the evaluation of a cell salvage service in hospitals of various sizes.

Entities:  

Mesh:

Year:  2007        PMID: 17377098     DOI: 10.1213/01.ane.0000258039.79028.7c

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  17 in total

Review 1.  Autologous blood in obstetrics: where are we going now?

Authors:  Giancarlo Maria Liumbruno; Chiara Liumbruno; Daniela Rafanelli
Journal:  Blood Transfus       Date:  2011-10-25       Impact factor: 3.443

2.  Implementation of an obstetric cell salvage service in a tertiary women's hospital.

Authors:  Eileen Lew; Shephali Tagore
Journal:  Singapore Med J       Date:  2015-08       Impact factor: 1.858

Review 3.  [Cell salvage].

Authors:  E Hansen; T Seyfried
Journal:  Anaesthesist       Date:  2011-04       Impact factor: 1.041

4.  The use of intraoperative cell salvage in urologic oncology.

Authors:  Matthew C Ferroni; Andres F Correa; Timothy D Lyon; Benjamin J Davies; Michael C Ost
Journal:  Rev Urol       Date:  2017

5.  Influence of autologous blood transfusion in liver transplantation in patients with hepatitis B on the function and hemorheology of red blood cells.

Authors:  Xiangfu Liu; Ruifang Fan; Ying Lu; Lihua Kuang; Qing Yuan; Yuchan Chen; Zhesheng Lin; Dongjun Lin
Journal:  Exp Ther Med       Date:  2017-06-13       Impact factor: 2.447

6.  Blood loss, predictors of bleeding, transfusion practice and strategies of blood cell salvaging during liver transplantation.

Authors:  Paolo Feltracco; Marialuisa Brezzi; Stefania Barbieri; Helmut Galligioni; Moira Milevoj; Cristiana Carollo; Carlo Ori
Journal:  World J Hepatol       Date:  2013-01-27

Review 7.  Intraoperative blood loss in orthotopic liver transplantation: The predictive factors.

Authors:  Chandra Kant Pandey; Anshuman Singh; Kamal Kajal; Mandeep Dhankhar; Manish Tandon; Vijay Kant Pandey; Sunaina Tejpal Karna
Journal:  World J Gastrointest Surg       Date:  2015-06-27

8.  A cost study of postoperative cell salvage in the setting of elective primary hip and knee arthroplasty.

Authors:  Vidya K Rao; Robert Dyga; Christopher Bartels; Jonathan H Waters
Journal:  Transfusion       Date:  2012-02-17       Impact factor: 3.157

9.  Cost-effectiveness Analysis of Intraoperative Cell Salvage for Obstetric Hemorrhage.

Authors:  Grace Lim; Vladyslav Melnyk; Francesca L Facco; Jonathan H Waters; Kenneth J Smith
Journal:  Anesthesiology       Date:  2018-02       Impact factor: 7.892

10.  Cell salvage for postpartum haemorrhage during vaginal delivery: a case series.

Authors:  Grace Lim; Eleni Kotsis; Jamie M Zorn; Patricia L Dalby; Catherine J Ralph; Jonathan H Waters
Journal:  Blood Transfus       Date:  2017-09-29       Impact factor: 3.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.